A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient and Post-Hospital Discharge Management of Medicine and Surgery Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 May 2017 Status changed from not yet recruiting to recruiting.
- 20 Apr 2017 Planned initiation date changed from 15 Apr 2017 to 1 May 2017.
- 30 Mar 2017 Planned initiation date changed from 1 Jan 2017 to 15 Apr 2017.